Narcolepsy can be described as a neurological condition that has chronic consequences on the regulation of the sleep-wake ...

Oveporexton, a novel first-in-class OX2R-selective agonist, shows promise for improving memory, attention, and executive function in individuals with narcolepsy type 1.

ADHD medications work like sleep, not attention boosters, massive brain study reveals. For some kids, focus problems may be ...

The precision oncology market surged to $139.4 billion in 2025 and is racing toward $317.5 billion by 2035[1], driven by a fundamental shift in cancer treatment philosophy. Biomarker-guided therapy ...

If you are wondering whether Jazz Pharmaceuticals still represents good value after its run this year, or if the easy money has already been made, this article will walk you through what the numbers ...

The post His Boss Told Him To Reject All Requests That Weren’t Formatted Properly, So He Rejected A Request From The CTO Of ...

Her family brought her to the hospital, but they sent her home a month later, with a diagnosis that made no sense at all.

Takeda has said it intends to move quickly ahead with regulatory filings for oveporexton, its orexin agonist for sleep disorder narcolepsy, after a clean sweep of positive efficacy data in two phase 3 ...

We carry these mixed feelings into 2026, which is slated to be another great—yet perhaps troubled—year for science. No list ...

All, the fast-growing K-pharmacy skincare brand founded by CEO Junho Jung, hosted its inaugural Dr. Reju-All Global Symposium at the Four Seasons Hotel Seoul, convening more than 300 pharmacists, ...

Tai Chi delivers slower but sustained improvements in chronic insomnia, eventually matching CBT-I in long term sleep outcomes.

Image Comics Full March 2026 Solicitations - from Transformers to Die: Loaded, from Spawn to Feral, from Youngblood to ...